Search Back New search Go to resultsDiseaseMain groupHematologic NeoplasmsProtocol groupIndolent LymphomasDiseaseNHL, B-Cell Type, Malt LymphomaSubgroupICD10C85.9C88.4-MeSHLymphoma, B-Cell, Marginal ZoneSequenceIELSG-19 trial: CHLO6, MALT lymphoma, C1 (PID2568) -|- CHLO6, C2-5 (PID2569)RITU375/CHLO6, MALT Marginal Zone B-NHL, C1 (PID1971) -|- C2-5 (PID1974)ChemotherapyChemo-substanceChlorambucilRituximabChemo-substanceChlorambucilRituximabChemo-substanceChlorambucilRituximabChemo-substanceChlorambucilRituximabNo. Substances12 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDimetindenParacetamolPrednisoloneSupportive substanceBalanced Crystalloid SolutionDimetindenParacetamolPrednisoloneSupportive substanceBalanced Crystalloid SolutionDimetindenParacetamolPrednisoloneSupportive substanceBalanced Crystalloid SolutionDimetindenParacetamolPrednisoloneNo. Substances4Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationFirst lineseveral possibleTherapy phaseConsolidationInductionTherapy intentiondisease controlpalliativeRisksAnemia Hb below 8g/dlConstipationDiarrheaEmetogenicity (MASCC/ESMO)Febrile NeutropeniaIncrease AminotransferasesInfectionsInfusion ReactionLeukopeniaLymphopeniaMucositisNeutropeniaPyrexiaRashThrombocytopenia below 50 000/µl only studiesPublicationAuthorConconi AZucca EDiseaseExtranodales Marginalzonen-B-NHL MALT Typ, Erst- und ZweitlinieMALT-Lymphom, auch gastrisches, neu diagnostiziert oder nach lokaler TherapieMarginalzonen-B-NHL MALT TypOriginOncology Institute of Southern Switzerland, Bellinzona, IELSG-19 trialOncology Institute of Southern Switzerland, Bellinzona, IELSG-19 TrialOncology Institute of Southern Switzerland, Division Medical Oncology, Bellinzona, SchweizProtocols in Revision 5 protocols foundProtocols under revision.Chlorambucil 6, MALT lymphoma, cycle 1 (PID2568 V1.0)Chlorambucil 6, MALT lymphoma, cycle 2-5 (PID2569 V1.0)Rituximab 375 / Chlorambucil 6, MALT Lymphoma, cycle 1 (PID1971 V1.1)Rituximab 375 / Chlorambucil 6, MALT Lymphoma, cycle 2-5 (PID1974 V1.1)Rituximab 375, MALT Lymphoma (PID353 V1.1)
